Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2003

View Archived Issues

Atazanavir-containing regimens in the management of HIV-1 infection

Multibinding beta2-adrenoceptor agonists designed by Theravance researchers

Stimulation of the dopamine D4 receptor enhances novelty-seeking behavior in mice

Glucagon antagonists/inverse agonists in Novo Nordisk pipeline

Pfizer patent covers new bicyclic FTase inhibitors

Pemetrexed in combination with cisplatin significantly extends survival in mesothelioma patients

New AMPA receptor modulators and their use claimed by Servier

GSK scientists prepare and test new cathepsin K inhibitors

Cholesterol management vaccine is a feasible human therapy

New prodrugs of dopamine D1 receptor agonists with utility in Parkinson's disease

Novel NOS inhibitors and their use in neurological disorders reported by Schering AG

Preclinical profile of a novel noncompetitive AMPA receptor antagonist, YM-928

Shire BioChem acquires Canadian rights to five Draxis products

Axcan acquires license to drug for treatment of hepatic encephalopathy

Cell Genesys and Novartis enter oncolytic virus therapy alliance

OPC-6535 enters two pivotal trials in ulcerative colitis

Savient acquires huperzine A marketing rights for U.S. and Europe

Orphan drug status awarded to Transgene's Ad-IFNgamma

Xenova updates R&D reorganization status

Phase III Noxafil study meets primary endpoint

Sweden is the first to approve transplant drug Certican

Anti-gp75 antibodies evaluated as potential therapies for melanoma

Humanized antibodies targeting denatured collagen inhibit angiogenesis and tumor growth

ZK-EPO: a promising new synthetic epothilone tubulin stabilizer

Pharma Mar remains fully confident in the efficacy of Yondelis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.